VIMOVO

Страна: Израиль

Язык: английский

Источник: Ministry of Health

Активный ингредиент:

ESOMEPRAZOLE AS MAGNESIUM TRIHYDRATE 20 MG; NAPROXEN 500 MG

Доступна с:

ASTRA ZENECA ISRAEL LTD

код АТС:

G02CC02

Фармацевтическая форма:

TABLETS MODIFIED RELEASE

Администрация маршрут:

PER OS

Производитель:

ASTRA ZENECA AB., SWEDEN

Терапевтическая группа:

NAPROXEN

Терапевтические показания :

Vimovo is a combination product that contains naproxen and esomeprazole. It is indicated for the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis and to decrease the risk of developing gastric ulcers in patients at risk of developing NSAID-associated gastric ulcers.Vimovo is not recommended for initial treatment of acute pain because the absorption of naproxen is delayed compared to absorption from other naproxen-containing products.

Дата Авторизация:

2011-12-01